Xu, Fanxi
Huang, Sen
Li, Xu-Ying
Lin, Jianing
Feng, Xiuli
Xie, Shu
Wang, Zhanjun
Li, Xian
Zhu, Junge
Lai, Hong
Xu, Yanming
Huang, Xusheng
Yao, Xiaoli
Wang, Chaodong
Funding for this research was provided by:
National Natural Science Foundation of China (82171412, 82171412, 82171412, 82171412, 82171412, 82171412, 82171412)
Ministry of Science and Technology (2016YFC1306000, 2016YFC1306000, 2016YFC1306000, 2016YFC1306000, 2016YFC1306000, 2016YFC1306000, 2016YFC1306000)
Special Fund from Key laboratory of Neurodegenerative Diseases, Ministry of Education of China (PXM2019_026283_000002, PXM2019_026283_000002, PXM2019_026283_000002, PXM2019_026283_000002, PXM2019_026283_000002, PXM2019_026283_000002, PXM2019_026283_000002)
National Key Research and Development Program of China (2017YFC0907703, 2017YFC0907703, 2017YFC0907703)
Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases (2020B1212060017, 2020B1212060017, 2020B1212060017)
Guangdong Provincial Clinical Research Center for Neurological Diseases (2020B1111170002, 2020B1111170002, 2020B1111170002)
the Southern China International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases (2015B050501003, 2015B050501003, 2015B050501003)
Article History
Received: 15 December 2021
Accepted: 30 July 2022
First Online: 5 August 2022
Declarations
:
: All research participants or their legal representatives signed informed consent forms for participation in clinical and genetic research. This study was approved by the institutional ethics board of Xuanwu Hospital of the Capital Medical University (Clinical Research Audit: [2021]034) and The China Human Genetic Resource Administration Office (China Ministry of Science and Technology Genetics Audit: [2021] CJ1167). In this study, all methods were performed in accordance with the relevant guidelines and regulations in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no conflicts of interest.